Chenzhang Shang

机构：Beijing Biocytogen (China)

发表论文 2 篇 · 总被引 9 次 · h-index 2

代表论文

• Abstract 6325: A novel EGFR x MUC1 bispecific antibody-drug conjugate, BSA01, targets MUC1 transmembrane cleavage products and improves tumor selectivity (2023 · Cancer Research · 被引 5)
• Abstract LB214: A first-in-class bispecific antibody-drug conjugate (DM002) targeting HER3 and the juxtamembrane domain of MUC1 (2023 · Cancer Research · 被引 4)